Nocturnal hypoxaemic burden is associated with incident major adverse cardiovascular events in patients with type 2 diabetes
In the present study, NHB was associated with MACE in patients with T2D and can be easily measured using oximetry. Further investigations are warranted to establish T90 reduction as a clinically meaningful treatment target.
Authors
- Frederick Sinha (ORCID: https://orcid.org/0000-0003-4260-6767)
- Mathias Baumert (ORCID: https://orcid.org/0000-0003-2984-2167)
- Lukasz Kmiec (ORCID: https://orcid.org/0000-0003-2831-0492)
- Michael Arzt (ORCID: https://orcid.org/0000-0002-4408-722X)
- Florian Zeman (ORCID: https://orcid.org/0000-0002-8425-984X)
- Klaus Stark (ORCID: https://orcid.org/0000-0002-7832-1942)
- Sarah Driendl
- Jan Pěč (ORCID: https://orcid.org/0009-0001-4661-1232)
- Stefan Stadler (ORCID: https://orcid.org/0000-0002-8783-618X)
Institutions
- University Hospital Regensburg (DE)
- Center for Clinical Studies (US)
- The University of Adelaide (AU)
Publication Details
- Journal
- European Journal of Preventive Cardiology
- Published
- 2025-04-27
- DOI
- https://doi.org/10.1093/eurjpc/zwaf259
- Citations
- 4
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- article
- Field-Weighted Citation Impact
- 6.07